oa SA Pharmaceutical Journal - Osteoarthritis : clinical

Volume 73, Issue 10
  • ISSN : 2221-5875
  • E-ISSN: 2220-1017



OA results from a combination of factors that include genetic predisposition, joint integrity, local mechanical forces and inflammatory responses. <br>Traditionally, OA has been divided into primary or secondary type. <br>The joint involvement in the primary form often affects the hands, feet, knee, hip and spine. <br>Secondary OA often follows on an insult to a joint, e.g. trauma, inflammation from rheumatoid arthritis, joint sepsis or crystal deposition. <br>The primary pathology in OA is articular cartilage failure. <br>Risk factors are age, female gender, obesity, muscle weakness, a combination of exercise with proprioceptive defects, and calcium crystal pyrophosphate deposition disease. <br>The diagnosis of OA remains a clinical one, based on patient history, examination and radiographic findings. <br>The aims of management are to control pain, improve quality of life and prevent progression of the disease. <br>Non-pharmacological therapy includes weight management, short-term rest and low-impact exercise. <br>Pharmacological treatment should start with paracetamol. Tramadol may be added and NSAIDs are sometimes used, but must be administered with caution, particularly in the elderly. <br>Intra-articular glucocorticoid therapy can be useful, as can diseasemodifying drugs. <br>Surgery is reserved for patients with intractable pain in whom nonpharmacological and pharmacological management have failed, or who suffer loss of function.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error